Gregory Feldman, MD
Founding Member, Consulting MD
Pulmonary Diseases, Critical Care and Internal Medicine.
During the pandemic, Dr. Feldman was the highest enrolling investigator on Moderna’s COVID-19 Vaccine study which resulted in a significant reduction in this lifesaving vaccine’s EUA timeline.
Dr. Feldman’s extensive experience informs MBR’s Standard Operating Procedures, optimizing high patient enrollment without compromising rigorous compliance with Good Clinical Practice.
After attending medical school at Second Moscow Medical Institute, Dr. Feldman completed his Pulmonary and Critical Care training at Dartmouth-Hitchcock Medical Center, Hanover, NH.